Literature DB >> 28410357

Donor Endothelial Cell Count Does Not Correlate With Descemet Stripping Automated Endothelial Keratoplasty Transplant Survival After 2 Years of Follow-up.

Ivan O Potapenko1, Branka Samolov, Margareta Claesson Armitage, Berit Byström, Jesper Hjortdal.   

Abstract

PURPOSE: To analyze the influence of low endothelial cell density (ECD) of donor cornea tissue, donor age, and sex on the transplant survival rate after Descemet stripping automated endothelial keratoplasty (DSAEK).
METHODS: Graft ECD, age, and sex of donors used for DSAEK (n = 1789) during 7 years (2007-2014) in 4 Scandinavian hospitals were assessed for potential association with transplant survival at 2 years of follow-up using a Cox regression model correcting for confounding factors. The data were obtained from The Swedish Cornea Transplant Registry.
RESULTS: Transplant failure occurred in 196 patients, with 69 early failures during the first 3 postoperative months, and 127 late secondary failures. Twenty-five of the late secondary failures were due to rejection. Reversible rejections occurred in 67 patients. There was no significant impact of donor age [hazard ratio (HR) 1.0, 95% confidence interval (CI), 0.99-1.02, P = 0.32] or endothelial cell count (HR 1.00, 95% CI, 0.99-1.01, P = 0.3) on the survival rate of DSAEK transplants at 2 years of follow-up. The use of donor grafts with low ECD (<2300 cells/mm) did not influence the survival rate (HR 1.3, 95% CI, 0.76-2.35, P = 0.31). Male donor sex was associated with lower 2-year graft survival (HR 1.5, 95% CI, 1.04-2.28, P = 0.03), but not with rejection events (P = 0.26).
CONCLUSIONS: Based on data from The Swedish Cornea Transplant Registry, low donor ECD was not detrimental to graft survival, whereas donor sex seemed to influence the outcome at the end of the 2-year follow-up.

Entities:  

Mesh:

Year:  2017        PMID: 28410357     DOI: 10.1097/ICO.0000000000001189

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study.

Authors:  Jonathan H Lass; Beth Ann Benetz; Sanjay V Patel; Loretta B Szczotka-Flynn; Robert O'Brien; Allison R Ayala; Maureen G Maguire; Yassine J Daoud; Mark A Greiner; Sadeer B Hannush; W Barry Lee; Thomas F Mauger; Harry J Menegay; Mark D Mifflin; Michael B Raizman; Jennifer Rose-Nussbaumer; Robert L Schultze; Gregory A Schmidt; Alan Sugar; Mark A Terry; David D Verdier
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

2.  The Effects of Donor-Recipient Age and Sex Compatibility in the Outcomes of Deep Anterior Lamellar Keratoplasties.

Authors:  Hon Shing Ong; Nathalie Chiam; Hla Myint Htoon; Ashish Kumar; Anshu Arundhati; Jodhbir S Mehta
Journal:  Front Med (Lausanne)       Date:  2022-01-27

3.  Donor-Related Risk Factors for Graft Decompensation Following Descemet's Stripping Automated Endothelial Keratoplasty.

Authors:  Sota Nishisako; Takefumi Yamaguchi; Masatoshi Hirayama; Kazunari Higa; Dai Aoki; Chiaki Sasaki; Hisashi Noma; Jun Shimazaki
Journal:  Front Med (Lausanne)       Date:  2022-02-04

4.  Donor and Recipient Sex Matching and Corneal Graft Failure in High-Risk and Non-High-Risk Patients.

Authors:  Asaf Achiron; Tal Yahalomi; Idan Hecht; Nir Stanescu; Romi Achiron Noy; Zvia Burgansky-Eliash; Haggai Avizemer; Raimo Tuuminen; Oriel Spierer
Journal:  J Ophthalmol       Date:  2022-04-16       Impact factor: 1.974

Review 5.  The Cologne-Mecklenburg-Vorpommern DMEK Donor Study (COMEDOS) - design and review of the influence of donor characteristics on Descemet membrane endothelial keratoplasty (DMEK) outcome.

Authors:  Silvia Schrittenlocher; Mario Matthaei; Björn Bachmann; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 3.535

6.  Endothelial failure and rejection in recipients of corneas from the same donor.

Authors:  Lewis Downward; Mahmoud Ahmed; Cathy Hopkinson; Vito Romano; Elinor Curnow; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.